A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101.

Immunology and Microbiology

• Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae 100%
• Bacterial Growth 100%
• Cell Wall 50%
• Scanning Electron Microscopy 50%
• Immunomodulating Drugs 50%
• Transmission Electron Microscopy 50%
• Minimum Inhibitory Concentration 50%
• Porin 50%
• Cell Death 50%
• X Ray 50%
• Cytolysis 50%
• Klebsiella pneumoniae 50%
• Growth Inhibition 50%

Keyphrases

• AS101 100%
• Tellurium Compounds 100%
• Antimicrobial Therapy 100%
• Extended-spectrum beta-lactamase-producing Klebsiella Pneumoniae 100%
• Klebsiella Pneumoniae (K. pneumoniae) 30%
• Bacterial Growth 20%
• Cysteamine 20%
• Producing Strain 20%
• Extended-spectrum beta-lactamase-producing 20%
• Dose Effect 10%
• X-ray Microanalysis 10%
• Scanning Electron Microscopy 10%
• Transmission Electron Microscopy 10%
• Rich Media 10%
• Growth Inhibition 10%
• Pneumonia Infection 10%
• Cell Lysis 10%
• Ammonium 10%
• Immunomodulator 10%
• Tellurate 10%
• Cell Death Pathways 10%
• Porin 10%
• Lag Phase 10%
• Na+-K+ Pump 10%
• Bacterial Degradation 10%
• 2-mercaptoethanol 10%
• Log Phase 10%
• Protein-rich 10%
• Antibiotic Resistant 10%
• 2-methoxyestradiol 10%
• Cell Wall Degradation 10%
• Antibacterial Potential 10%